Clariant returns to profitable growth, increasing both sales and profitability in the first quarter of 2021
- Sales from continuing operations increased by 2 % in local currency to CHF 1.002 billion, reflecting a broad recovery in our markets
- EBITDA of CHF 164 million rose by 4 % in Swiss francs, generating a notably improved EBITDA margin at 16.4 % (vs. 15.4 %)
- Pricing actions have been initiated to offset rising raw material and logistics cost
- Outlook 2021 Continuing Operations: moderate local currency sales growth and a step up in EBITDA margin to slightly above pre-COVID-19 pandemic levels
“The first quarter of 2021 demonstrated both Clariant’s return to growth as well as a sequential improvement in the Group’s performance. This progression was achieved through our portfolio of attractive businesses and the disciplined execution of our strategy and performance improvement programs,” said Conrad Keijzer, CEO of Clariant. “I would like to thank our teams for effectively mastering the current challenges amidst the continued COVID-19 pandemic; rising raw material cost as well as disruptions in supply chains. In 2021, we strive to make an important step up in our performance and expect Clariant to achieve moderate sales growth in local currency and a recovery in EBITDA margins to slightly above pre-COVID-19 pandemic levels. With our partnership with India Glycols Limited for green surfactants, we continue to advance our portfolio transformation toward a higher specialty value business.”
Key Financial Data
|Continuing operations||First Quarter|
|in CHF million||2021||2020||% CHF||% LC|
|Sales||1 002||1 019||-2||2|
|- margin||16.4 %||15.4 %|
|EBITDA before exceptional items||168||163||3|
|- margin||16.8 %||16.0 %|
First Quarter 2021 – Progression towards mid-term targets
Muttenz, April 29, 2021 - Clariant, a focused, sustainable, and innovative specialty chemical company, today announced first quarter 2021 continuing operations sales of CHF 1.002 billion, compared to CHF 1.019 billion in the first quarter of 2020. This corresponds to a 2 % increase in local currency, whereas depreciating currencies led to a 2 % decrease in Swiss francs. The local currency expansion was driven by positive pricing.
On a regional basis, sales in Europe increased by 17 % in local currency due in part to the weather-related improvement in the Aviation business. Sales in Asia also grew by 9 %, driven by the economic recovery and the undemanding comparison base in China in the first quarter of 2020. This improvement was followed closely by Latin America, where sales rose by 4 %. Sales in the Middle East & Africa declined by 9 %, while North America was 27 % lower primarily driven by the continued challenging environment in Oil Services and the business disruptions in Texas due to the winter storms.
The Care Chemicals Business Area increased sales by 7 % in local currency due to improvements in both Consumer Care as well as Industrial Applications in the first quarter of 2021. Catalysis sales rose by a notable 10 % in local currency primarily due to the strong sales development in Petrochemicals. Natural Resources sales declined by 6 % in local currency due to the particularly challenging comparison base in the first quarter of 2020 as well as the continued weakness in the Oil and Refinery businesses.
The continuing operations EBITDA rose by 4 % in Swiss francs to CHF 164 million, positively influenced by the sales expansion in the first quarter of 2021 and the efficiency program-driven cost savings in the amount of CHF 6 million, which generated improvements in each of the three Business Areas. As a consequence, the EBITDA margin improved significantly to 16.4 % versus 15.4 % in the same period of the previous year.
For the first quarter of 2021, on a like-for-like basis, sales in discontinued operations (Pigments) increased by 4 % in local currency and remained unchanged in Swiss francs.
The EBITDA decreased in absolute value year-on-year due to the divestment of the Masterbatches business. The profitability of the underlying Pigments businesses was positively impacted by the higher sales as well as the execution of the efficiency program.
A Clariant subsidiary in the United States has been named along with many other defendants in lawsuits involving per- and polyfluoroalkyl substances (PFAS). Clariant is monitoring the development of these cases, which relate to the respective business divested in 2013, and is defending all litigation matters related to PFAS. As of this point in time, Clariant cannot assess if these litigations will have a material impact on Clariant’s financial results.
Outlook – Focused portfolio to achieve above-market growth, higher profitability, and stronger cash generation in the mid-term
Clariant is a focused, sustainable, and innovative specialty chemical company that aims to grow above the market to achieve higher profitability through sustainability and innovation. The Group is significantly reshaping its portfolio through the divestment of Healthcare Packaging in 2019, the sale of Masterbatches in 2020, and the planned divestment of Pigments.
For the second quarter of 2021, Clariant expects moderate growth in local currency versus the prior year among all three Business Areas driven by the recovery of Industrial Applications in Care Chemicals, demand for Petrochemicals in Catalysis, and continued growth in Additives and Functional Minerals in Natural Resources. Clariant aims to defend its first quarter 2021 margins in the second quarter of 2021 via cost discipline and pricing actions to overcome the rise in raw material, and logistics cost. Looking at the full year 2021, Clariant expects to achieve moderate local currency sales growth in continuing operations and a step up in EBITDA margin to slightly above pre-COVID-19 pandemic levels on the back of the growth of its specialty portfolio and the positive impact of the performance programs. This is based on an assumption of a continued economic recovery, while uncertainty remains high.
In the mid-term, Clariant expects its continuing businesses to achieve above-market growth, higher profitability, and stronger cash generation based on the focused three pillars and high value specialty portfolio.
|CORPORATE MEDIA RELATIONS||INVESTOR RELATIONS|
Phone +41 61 469 63 63
Phone +41 61 469 63 73
Phone +41 61 469 63 63
Phone +41 61 469 63 73
Phone +41 61 469 63 63
Phone +41 61 469 63 73
Follow us on Twitter, Facebook, LinkedIn, Instagram.
|This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.|
Clariant is a focused and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2020, the company employed a total workforce of 13 235. In the financial year 2020, Clariant recorded sales of CHF 3.860 billion for its continuing businesses. The company reports in three business areas: Care Chemicals, Catalysis and Natural Resources. Clariant’s corporate strategy is based on five pillars: focus on innovation and R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Mandalay Resources Corporation tillkännager resultatrapporten för första kvartalet 202115.5.2021 14:02:50 CEST | Pressemelding
TORONTO, May 15, 2021 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) tillkännager resultatrapporten för kvartalet som slutade den 31 mars 2021. Bolagets sammanfattade och konsoliderade delårsrapporter för kvartalet som slutade den 31 mars 2021, tillsammans med ledningens diskussion och analys (”MD&A”) för samma period, finns tillgängliga under bolagets profil på www.sedar.com och på bolagets webbplats www.mandalayresources.com. Alla valutor i detta pressmeddelande avser US-dollar om inget annat anges. Höjdpunkter för första kvartalet 2021: Kvartalsintäkter på 52,6 miljoner USD, de högsta sedan andra kvartalet 2016;Justerad EBITDA på 26,1 miljoner USD, det tredje högsta i bolagets historia;Justerat nettoresultat på 5,6 miljoner USD (0,06 USD eller 0,08 CAD per aktie); ochKonsoliderat nettoresultat på 25,5 miljoner USD (0,28 USD eller 0,35 CAD per aktie). Dominic Duffy, styrelseordförande och CEO på Mandalay, kommenterar: ”Mandala
Antal aktier i Nexstim Abp efter första momentet i processen för att minska antalet aktier14.5.2021 20:00:00 CEST | Pressemelding
Företagsmeddelande,Helsingfors, 14.5.2021 kl. 21.00 (EEST) Antal aktier i Nexstim Abp efter första momentet i processen för att minska antalet aktier Bolagsstämman av Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) fattade 11 maj 2021 beslut om att minska antalet aktier i bolaget utan att minska aktiekapitalet genom att vederlagsfritt ge ut nya aktier till aktieägarna, och genom att vederlagsfritt lösa in bolagets egna aktier så att hundra (100) nuvarande aktier i bolaget ska motsvara en (1) aktie efter att arrangemangen för att minska antalet aktier i bolaget har genomförts. Som en del av arrangemangen med avseende på de aktieägare som på transaktionsdagen (enligt definitionen nedan) är registrerade i Nexstims aktieägarförteckning hos Euroclear Finland Ab fattade bolagsstämman beslut om att bolaget ska 14 maj 2021 (”transaktionsdagen”) vederlagsfritt emittera högst 1 000 000 nya aktier så att antalet aktier per värdeandelskonto som ägs av dessa aktieägare är delbart med
Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares14.5.2021 20:00:00 CEST | Press release
Company announcement,Helsinki, 14 May 2021 at 9 PM (EEST) Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares Annual General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) resolved on 11 May 2021 to reduce the quantity of Nexstim's shares without reducing share capital by way of issuing new shares to its shareholders without consideration, and by redemption of Company's own shares without consideration, in such a way that each current 100 shares of the Company shall correspond to one share of the Company after the arrangements related to the reduction of the quantity of Company's shares are completed. As a part of the arrangements in respect of shareholders registered on the Transaction Day (as defined below) in the shareholders’ register of Nexstim held by Euroclear Finland Ltd, the Annual General Meeting resolved that the Company shall issue on 14 May 2021 (the "Transaction Day") a maximum of 1,000,000 new s
IMCD Colombia expands into new markets through the acquisition of Siliconas y Químicos14.5.2021 20:00:00 CEST | Press release
ROTTERDAM, The Netherlands (14 May 2021) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Colombia acquired the Colombian speciality distributor, Siliconas y Químicos S.A.S. (“Siliconas y Químicos”). “We are delighted to further expand our presence in Latin America with the acquisition of Siliconas y Químicos,” said Marcus Jordan, Americas President, IMCD. “The company’s strategy of being ‘Specialists in Specialities’ closely aligns with IMCD and its expertise in personal care, coatings, silicones, and other speciality industrial markets perfectly complements our existing pharmaceuticals, food and nutrition business in Colombia.” Based in Bogotá, Siliconas y Químicos has experienced steady growth since its inception in 2000, generated a revenue of USD 9 million in 2020, and adds 25 employees to the IMCD Colombia team. Siliconas y Químicos is ISO 9001:2015 certified and operates across Colombia with strategic out
Touax: Q1 2021 restated revenues from activities14.5.2021 17:45:00 CEST | Press release
PRESS RELEASE Paris, 14 May 2021 – 5.45 p.m. YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Q1 2021 restated revenues from activities Restated revenues from activities amounted to €24.6m in Q1 2021, stable in constant dollars compared to the same period in 2020.Favourable outlook with a significant order book New segmentation of revenues betweenownedactivities and management activities. In order to enable a more detailed and more accurate reading of its activities, the Group decided to update the key indicators of its quarterly report: Revenues from activities are restated in order to present ownedactivities separately from management activities. For management activities, leasing revenue from investor-owned equipment is replaced by management fees, which correspond to the net contribution of the leasing management activity to the Group's performance. This presentation showssyndication fees, sales feesand now management fees, grouped together under management activity
CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER14.5.2021 16:20:00 CEST | Press release
Bid procedure, 2021-05-19CertificateCommercial paper issued in SEK by non-financial companies with their registered office in Sweden and with a remaining maturity of up to six months on the Bid date. i.e. with the latest maturity date as of 2021-11-19 Delivery may not be made in commercial paper purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Special terms, i.e. the purchase may not have been made after 2021-05-07 BidsCounterparties may make one bid per Credit rating class and maturity class. Bids are made to tel 08-696 69 70 and confirmed by e-mail to EOL@riksbank.se.Bid date2021-05-19Bid times09.00-09.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SEK 4 billionHighest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 4 billion. No bid may contain Commercial paper in excess of SEK 250 million issued by the s
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS14.5.2021 16:20:00 CEST | Press release
Bid procedure, 2021-05-21BondsSWEDISH GOVERNMENT: 1053. SE0002829192. 2039-03-30 SWEDISH GOVERNMENT: 1063, SE0015193313, 2045-11-24 Bid date2021-05-21Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)1053: 750 mln SEK +/-350 mln SEK 1063: 500 mln SEK +/-250 mln SEK Highest permitted bid volume (corresponding nominal amount)1053: 750 mln SEK per bid 1063: 500 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2021-05-25Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2021-05-14 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions c